Introduction
Inflammatory bowel disease (IBD) is a chronic, relapse-prone disease of rising worldwide prevalence [1] . Because IBD is currently incurable, disease flareups are treated symptomatically with anti-inflammatory medication. Current therapeutic strategies for IBD remain unsatisfactory because of significant side effects of long-term drug administration and the proportion of nonresponders [2] [3] [4] [5] .
Active IBD is characterized by neutrophilic infiltration of the intestine and loss of intestinal function. Dextran sodium sulfate (DSS) and trinitrobenzene sulfonic acid (TNBS) are two colitogenic chemicals commonly administered to mice to recapitulate aspects of IBD [6] . While murine IBD models are informative platforms for investigating disease etiology, they are prohibitively expensive platforms for performing in vivo drug screens. Zebrafish models of chemically induced enterocolitis and their relevance to IBD have been previously reported and could provide a low-cost animal model of acute colitis for the initial stages of anti-inflammatory drug discovery programs [7, 8] . Furthermore, the tractable genetics of the zebrafish model system have been applied to interrogating the function of IBD susceptibility genes and susceptibility factors [9] [10] [11] [12] .
Whole animal chemical screens have been carried out using several well-established invertebrate and veterbrate model systems including worms, flies, and fish [13] [14] [15] . Zebrafish embryos and larvae have emerged as especially useful platforms to carry out in vivo drug screens for inflammatory diseases as drugs can be added directly into their liquid media [16] [17] [18] [19] . In this study, zebrafish models of enterocolitis have been applied to perform a drug repurposing study to identify modifiers of neutrophilic inflammation.
Results

A chemical screen approach identifies enterocolitis-modifying small molecules
Previous investigations had identified neutrophilic distribution as a live readout of inflammation in larval zebrafish enterocolitis models following addition of enterocolitic agents to the larval media ( Fig. 1A ) [20] .
Under physiological conditions, neutrophils are primarily located in the caudal hematopoietic tissue in zebrafish larvae. Exposure to enterocolitic agents causes both a quantitative increase in total neutrophil number, and a qualitative change in neutrophil localization to the intestine and trunk [8, 10] . To analyze neutrophilic inflammation in a medium throughput manner in our screening assay, we assayed the localization of neutrophils in the intestine and trunk by live imaging of 6 day post fertilization (dpf) Tg(mpx:EGFP) i114 larvae, where neutrophils are marked by expression of enhanced green fluorescent protein (EGFP) [21] . This phenotype had been previously shown to be responsive to treatment with known antibiotics and anti-inflammatory IBD drugs [8] . Conversely, examination of this phenotype can also be leveraged to detect stimuli that exacerbate inflammation [10, 11] .
The 1500+ compound John Hopkins Clinical Compound Library (JHCCL) was used in this study as it is: (a) publically available, (b) consists of wellcharacterized drugs aiding the elucidation of targeted pathways, and (c) grouped by drug indication allowing validation of the model based on the predicted classes of drug hits.
By independently screening for anti-inflammatory activity in both the DSS and TNBS enterocolitis backgrounds (Fig. 1B, Table S1 ), a first pass screen identified 118 hits with decreased neutrophil mobilization (anti-inflammatory activity in 2/2, 2/3, or 3/3 surviving larvae per well) compared to untreated controls in either one or both of the enterocolitis models. An additional 80 compounds were identified with increased neutrophil mobilization beyond untreated controls and 15 compounds were found to induce neutrophil depletion (Tables S2 and S3) . Severe toxicity was assessed as compounds that increased larval mortality beyond the average mortality seen in control wells. A total of 208 compounds were designated toxic by this measure, 162 from DSS and 46 from TNBS with no overlap between models (Table S4) .
Analysis of drug indication was used to validate the fidelity of the IBD-like neutrophilic inflammation phenotype of the zebrafish enterocolitis models (Fig. 1C) . It was predicted that because of the microbiota dependence of neutrophilic inflammation in the DSS and TNBS models [8, 10] , antibiotic drugs would be overrepresented in the anti-inflammatory drug hits. Indeed, of the 118 first pass hits, containing 141 drug indications, the broad grouping of antibacterial, antibiotic, and antiseptic indications were enriched in the first pass anti-inflammatory drug hits compared with the total composition of the JHCCL. Of note, both the glucocorticoid drug prednisolone (a mainstay IBD therapy) and kanamycin (used experimentally to deplete the microbiota) were both detected in the first pass screen confirming the fidelity of the model (Table S1 ).
First pass hits were rescreened with a more stringent cutoff requiring decreased neutrophil mobilization in all larvae. This reduced the number of compounds selected for further study from 118 to 23. Of the confirmed hits (Table 1) , containing 28 drug indications, antibiotic-type drugs were again over-represented (Fig. 1C) .
Although not originally indicated in the drug library for use as antibiotic, literature analysis revealed an antibiotic-like activity for chlorobutanol [22] . Five of the 23 confirmed hits had potential anti-inflammatory effects, namely eptifibatide, through inhibition of platelet activation, fludrocortisones and prednisolone as steroids, and tecastemizole and tiotidine through inhibition of histaminic pathways.
Of the remaining compounds, the antidiarrheal compound bismuth subsalicylate (the active ingredient in Pepto-Bismol, Procter and Gamble) has been suggested to be an efficacious adjuvant therapy for IBD [23, 24] , and the use of hydroxyprogesterone caproate has been proposed as an anti-inflammatory therapy (United States Patent US 2005/0203073 A1).
Analysis of the known targets of the remaining nine confirmed hits revealed both apocodeine and cabergoline as dopamine agonists [25, 26] . As abnormalities in the dopamine-dopamine receptor 2 signaling axis are associated with both human IBD and acute colitis in mice [27] [28] [29] , we reasoned dopamine receptor agonists could be a therapeutic opportunity worth exploring for IBD.
Stimulation of cholecystokinin (CCK) signaling by sincalide has been shown to reduce acute colitis in rats [30] . Interestingly, our screen also detected a proinflammatory effect of the CCK receptor antagonist lorglumide that is consistent with observations of exacerbated acute colitis in rats treated with CCK receptor antagonists [30, 31] . As sincalide, as with cabergoline, has well defined molecular targets, we chose to further define the role of the CCK signaling pathway in our zebrafish acute enterocolitis models.
Pharmacologic manipulation of dopamine signaling modulates acute inflammation in zebrafish larvae
Of the two dopamine receptor agonists identified by chemical screening, we reasoned cabergoline was the best compound to study as it has fewer side effects than apocodeine [26] , an emetic (vomiting inducer), in humans. Initial titrations indicated cabergoline was well tolerated by zebrafish larvae at doses up to 100 lM. To examine the dose responsiveness of the 
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The FEBS Journal 284 (2017) 402-413 ª 2016 Federation of European Biochemical Societies neutrophilic inflammation phenotype, larvae were treated with doses of cabergoline from 5 to 50 lM and exposed to either DSS or TNBS for 3 days from 3 dpf (the dose of 3 lgÁmL À1 cabergoline used in the screen = 6.6 lM). DSS-and TNBS-induced neutrophilic inflammation was markedly suppressed by cabergoline at all doses examined. Quantification of neutrophilic inflammation by manual counting of intestine-associated neutrophils revealed neutrophilic inflammation was suppressed by doses above 5 lM cabergoline ( Fig. 2A,B) .
To examine a second measure of inflammation in the TNBS model, live imaging of nitric oxide production was performed using the nitric oxide-sensitive 4-amino-5-methylamino-2 0 , 7 0 -difluorofluorescein diacetate (DAF-FM-DA) probe [32, 33] . Cotreatment with 20 lM cabergoline for the duration of TNBS exposure visibly suppressed TNBS-induced nitric oxide production in the cleithrum and notochord of 6 dpf larvae without affecting physiological nitric oxide production by the heart (Fig. 2C) . Furthermore, the addition of 20 lM cabergoline at 5 dpf (2 days after the induction of inflammation by TNBS) successfully suppressed existing TNBS-induced nitric oxide production to baseline levels.
As cabergoline primarily acts as a dopamine receptor agonist, a pharmacological approach was used to examine the effect of antagonism of dopamine receptor signaling using the drug haloperidol. Initial titrations of haloperidol revealed severe developmental defects at doses above 10 lM (data not shown). A dose of 7.5 lM did not affect morphology or induce neutrophilic inflammation and was thus chosen for further studies. Quantification of neutrophilic inflammation in larvae cotreated with 7.5 lM haloperidol and a dose of either 0.25% or 0.5% DSS demonstrated increased neutrophilic inflammation in the presence of dopamine receptor antagonism (Fig. 2D) . However, haloperidol treatment did not affect neutrophilic inflammation (Fig. 2E ), or survival ( Fig. 2F) , following exposure to TNBS.
Pharmacologic manipulation of cholecystokinin signaling modulates acute enterocolitis in zebrafish larvae
Sincalide, a CCK receptor agonist, was detected as an anti-inflammatory hit in both the DSS and TNBS screens where doses of 3 lgÁmL À1 reduced intestinal neutrophil numbers. Titration of commercially available sincalide from concentrations up to 5 lM (3 lgÁmL À1 =~2.5 lM) replicated a trend to reduced intestinal neutrophil numbers in larvae exposed to DSS, although not to a statistically significant level after correction for multiple comparisons across the five titrated doses, and a statistically significant decrease in TNBS-induced intestinal neutrophil recruitment for doses of 1, 3, and 4 lM after correction for multiple comparisons (Fig. 3A,B) . Suppression of TNBS-induced inflammatory nitric oxide production by sincalide treatment was assessed by DAF-FM-DA fluorescent probe. However, we observed elevated DAF-FM-DA fluorescent signal in the cleithrum and notochord of control larvae treated only with sincalide (Fig. 3C ). This observation precluded further analysis of sincalide's effectiveness by this alternate measure of inflammation.
As lorglumide appeared to affect the morphology of the larval intestine in the chemical screen setting (data not shown), a second CCK receptor antagonist (devazepide) that did not affect intestinal morphology was included in further pharmacological analysis of CCK receptor signaling in inflammation. Compared with lorglumide (3 lgÁmL À1 =~7 lM), devazepide was not tolerated at doses above 5 lM and a working dose of 2.5 lM was utilized for further study. Final list of 23 drug hits from the confirmatory (second) round of screening. A hit in the confirmatory round required decreased neutrophil inflammation in all treated larvae in both the DSS and TNBS models. See Table S1 for the list of compounds analyzed in this assay.
Quantification of neutrophilic inflammation in larvae treated with either devazepide or lorglumide demonstrated that these drugs do not significantly increase inflammation in otherwise untreated larvae (Fig. 3D) . However, exposure to low doses of either DSS or TNBS synergized with both CCK receptor antagonists to markedly increase the number of intestine-associated neutrophils. Additional evidence of this proinflammatory effect was demonstrated by significantly reduced survival in groups treated with CCK receptor antagonists following exposure to high-dose TNBS (Fig. 3E ).
Differential effects of enterocolitis drug hits on systemic immunity
Systemic infection of zebrafish embryos by yolk sac injection of Salmonella enterica was employed to examine functional conservation of dopamine receptor signaling in the zebrafish model. Treatment of infected embryos with either the known immunosuppressant dexamethasone or the dopamine receptor agonist cabergoline significantly reduced postinfection embryo survival (Fig. 4) . However, treatment with the dopamine receptor antagonist haloperidol did not affect embryo survival compared with untreated embryos.
Analysis of CCK receptor modulation in the S. enterica systemic infection model did not reveal any significant differences in embryo survival (data not shown).
Discussion
This paper presents the results from the first acute enterocolitis small molecule chemical screen to be carried out in a vertebrate model. Using a library of well-characterized compounds, the tractability of the DSS-and TNBS-induced zebrafish enterocolitis models for detecting disease-modifying compounds was demonstrated by the detection of known antibiotics and anti-inflammatory compounds.
Our primary screening assay detected antiinflammatory hits at an 8% rate and proinflammatory hits at a 5% rate, together these rates are comparable to a recent study by Wittman et al. [17] that detected 6% rates in a primary screen of a copper sulfate inflammatory model. Our confirmatory rescreening of anti-inflammatory hits lowered our hit rate by 80% tõ 1.5% of the total library, the result of increased stringency.
The presence of 'blank' wells in the JHCCL allows us to calculate a false hit rate of 3% within the antiinflammatory hits from the primary screening assay. Reassuringly, the confirmatory rescreening eliminated these false hits from our pipeline.
Severe toxicity in our primary screen was observed for 14% of compounds in either the DSS or TNBS model. This figure is significantly higher than that seen for the copper sulfate model that detected a 4% toxicity rate. However, separation of the mortality counts by model results in a rate of 11% for DSS and 3% for TNBS. These rates suggest the DSS model is much more susceptible to drug-induced mortality than either the TNBS or copper sulfate models.
The convergence of inflammation-modifying hits onto the dopamine and CCK receptor signaling pathways was useful for the purpose of prioritizing compounds for further investigation. Expression profiling datasets (GSE12189 and GSE81913) demonstrate expression of dopamine and CCK receptors by zebrafish leukocytes and intestinal epithelial cells [34, 35] . Our infection experiments where cabergoline had an immunosuppressive effect in a model of systemic infection suggest a direct effect of dopamine receptor manipulation on zebrafish leukocytes. Conversely, the Representative images of DAF-FM-DA staining in 6 dpf wild-type larvae exposed to TNBS at 3 dpf and treated with cabergoline as indicated. Red arrowheads indicate constitutive heart staining, blue arrowheads indicate cleithrum and notochord position. Bottom left panel, both larvae display stereotypical TNBS-induced nitric oxide production. Scale bar indicates 1 mm. (E) Enumeration of intestinal neutrophils in larvae coexposed to DSS and 7.5 lM haloperiodol for 3 days from 3 dpf. n ≥ 11, two biological replicates. Error bars represent SEM, statistical analysis by t test. (F) Enumeration of intestinal neutrophils in larvae coexposed to TNBS and 7.5 lM haloperiodol for 3 days from 3 dpf. n ≥ 15, three biological replicates. Error bars represent SEM, statistical analysis by t test. (G) Survival of larvae coexposed to 75 lgÁmL À1 TNBS and 7.5 lM haloperiodol from 3 dpf. n ≥ 41, two biological replicates. Error bars represent 95% CI, survival curves were not significantly different (P = 0.8834) as determined by log-rank test. *P < 0.05, **P < 0.01, ***P < 0.001. biological replicates. Error bars represent 95% CI, survival of devazepide-treated and lorglumide-treated groups was significantly different from the control group (P < 0.0001) but not significantly different (P = 0.4974) from each other as determined by log-rank test. *P < 0.05, **P < 0.01, ***P < 0.001.
lack of effect of CCK receptor manipulation on the outcome of systemic infection points toward a role for intestinal epithelial cells in this inflammatory signaling axis.
Dopamine receptor signaling in IBD
Given the association of reduced endogenous dopamine production and responsiveness with human IBD [27, 29] , our study suggests oral administration of dopamine receptor agonists such as cabergoline may be worthy of further investigation as a therapeutic approach for IBD. As dopamine receptor agonists are widely prescribed for a range of diseases, this study raises the possibility that patients already receiving this treatment may be protected from IBD. Conversely, this study suggests that patients receiving dopamine receptor antagonists such as haloperidol for the treatment of psychiatric disorders could be at increased risk for developing inflammatory diseases and, specifically, triggering IBD. This hypothesis follows the observation by Magro et al. [27] that genetically determined low-density expression of the D2 dopamine receptor increases the risk of conventional therapy failure in Crohn's disease patients.
A previous study by Herak-Perkovic et al. [36] showed a protective effect of dopamine axis stimulation and a detrimental effect of dopamine axis antagonism in a mouse colitis model. Using a combination of chemical and genetic manipulation in Caenorhabditis elegans, a recent study by Cao and Aballay [37] has demonstrated neuron-derived dopamine modifies the immune response in a noncell autonomous manner. These observations parallel the clinical finding that dopamine levels are reduced in active IBD [29] . Together with the data from our study, there is now significant evidence that exogenous activation of dopamine receptors could have a protective effect against intestinal inflammation.
While dopamine receptor agonist treatment effectively suppressed both DSS-and TNBS-induced enterocolitis in our study, dopamine receptor antagonist treatment only worsened the enterocolitis induced by DSS. This suggests that DSS and TNBS exposures differentially evoke dopamine receptor signaling as an endogenous damage-limiting pathway (Fig. 5A) . We hypothesize that only DSS exposure invokes an endogenous dopamine counterinflammatory response, potentially through the erosive nature of its toxicity. Future experiments with alternative dopamineneutralizing strategies and assays to quantify the endogenous dopaminergic response to inflammation are necessary to prove this hypothesis.
CCK receptor signaling in IBD
Administration of CCK or stimulation of endogenous CCK production by dietary modulation has an antiinflammatory effect in several models of microbially stimulated inflammation, including chemically induced colitis in rats [30, 31, [38] [39] [40] [41] [42] [43] [44] . Our study reinforces CCK signaling as an effector of the anti-inflammatory effects of a high-fat diet and suggests a relationship may also exist between CCK receptor antagonist therapy and the risk of developing an inflammatory disease.
Our findings that treatment with CCK receptor antagonists exacerbated experimental enterocolitis in both of our models may reflect the existence of an endogenous CCK-dependent anti-inflammatory mechanism that limits inflammation in zebrafish exposed to DSS or TNBS (Fig. 5B) . Future studies may utilize the zebrafish model to modulate the endogenous production of CCK to protect against inflammatory pathologies.
The robustness of the neutrophilic inflammation phenotype in zebrafish larval enterocolitis models and the availability of other zebrafish models of neutrophilic inflammation mean that excellent platforms now exist for expanding immunomodulatory drug screening into in vivo models [16, 45, 46] . These models may also prove amenable to further mechanistic investigation of the immunomodulatory compounds identified in this report. Fig. 4 . Cabergoline suppresses systemic immunity. Survival of embryos infected with Salmonella enterica at 2 dpf and treated as indicated. n = at least 104, three biological replicates. Error bars represent 95% CI, survival of the cabergoline-treated group was significantly different from the control (P < 0.0001), dexamethasonetreated (P = 0.0003), and haloperidol-treated (P < 0.0001) groups; survival of the dexamethasone-treated group was significantly different from the control (P = 0.0009) and haloperidol-treated (P = 0.0227) groups; and survival of the haloperidol-treated group was not significantly different from the control group (P = 0.1348) as determined by log-rank tests.
Materials and methods
Zebrafish manipulations
Animal research was conducted with approval from The University of Auckland Animal Ethics Committee. Zebrafish larvae were anesthetized with 120 lgÁmL À1 tricaine (Sigma-Aldrich, St. Louis, MO, USA) prior to mounting for imaging. Zebrafish embryos were obtained from natural spawnings and raised at 28.5°C in E3 embryo medium supplemented with methylene blue until 1 dpf. E3 used after 1 dpf did not contain methylene blue, which has antimicrobial activity. Induction of enterocolitis by DSS or TNBS exposure was carried out essentially as previously described [20] . All analyses were performed at 6 dpf unless otherwise noted. Dexamethasone (Sigma-Aldrich), devazepide (Tocris Biosciences, Bristol, UK) and haloperidol (Sigma-Aldrich) were dissolved in dimethyl sulfoxide (DMSO). Cabergoline (Sigma-Aldrich) was dissolved in ethanol. Lorglumide and sincalide (Sigma-Aldrich) were dissolved in water.
Imaging
Whole mount imaging was carried out as previously described using a Nikon SMZ1500 stereomicroscope equipped with a DS-U2/L2 camera [8] . Histological imaging was carried out on a Leica DMR compound microscope with a DFC420C camera (Leica, Wetzlar, Germany). Further image analysis was carried out with IMAGEJ software Version 1.43 (National Institutes of Health, Bethesda, MD, USA).
Chemical screening
Working plates of the JHCCL were prepared at a concentration of 100 lgÁmL À1 in 24% DMSO. Three Tg(mpx:
were aliquoted into each well in a total volume of 1 mL E3 with a drug concentration of 3 lgÁmL À1 . Control groups were exposed to vehicle or water as some drugs in the JHCCL were found to be dissolved in aqueous media. Enterocolitis was induced by the addition of either DSS (final concentration 0.5%) or TNBS (final concentration 70 lgÁmL
À1
). Plates were incubated for 3 days at 28.5°C. Six dpf larvae were anesthetized and assessment of neutrophilic inflammation was carried out by epifluorescent microscopy; a hit was defined as 2/2, 2/3, or 3/3 larvae without evidence of increased tissue neutrophils. All firstround hits were replated from the master JHCCL plates, rescreened under the same conditions and reassessed with increased stringency (either 2/2 or 3/3 for confirmation). Haloperidol has no effect on TNBS-induced inflammatory response suggesting there may be no endogenous CCK-8 response to TNBS. Devazepide or lorglumide exacerbates the TNBS-induced inflammatory response suggesting endogenous dopamine may limit the extent of the TNBS-induced inflammatory response.
Neutrophil enumeration
Neutrophil enumeration from static fluorescent images of Tg(mpx:EGFP i114 ) larvae was carried out essentially as previously described [20] . Briefly, larvae were anesthetized in tricaine, immobilized in methylcellulose, and imaged by epifluorescent microscopy. Fluorescent neutrophils around the larval intestine were enumerated by manual counting.
Live imaging staining
DAF-FM-DA staining of nitric oxide production was performed as previously described using DAF-FM-DA (Invitrogen) [33] . Briefly, DAF-FM-DA in DMSO was added to larval media at a final concentration of 10 lM followed by incubation at 28.5°C for 2 h prior to imaging.
Salmonella yolk sac infection
Salmonella yolk sac injection infections were performed as previously described [20] . Briefly, GFP-labeled S. enterica serovar Typhimurium was grown overnight in LB broth shaking at 200 r.p.m. at 37°C. Salmonella was harvested by centrifugation and washed with PBS. Bacterial pellets were resuspended 1 : 1 in PBS and then diluted 1 : 100 in PBS to achieve a concentration of approximately 200 CFUÁnL
À1
. Anesthetized 2 dpf embryos were mounted in methylcellulose and injected with 1 nL of the diluted Salmonella suspension.
Statistical analysis
All statistical analyses were carried out with GRAPHPAD PRISM version 5.0a for MAC (GraphPad Software, La Jolla, CA, USA).
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